Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Cardinal Health (CAH – Research Report) yesterday and set a price target ...

Law enforcement increasingly sees cannabis not as a criminal matter, but a regulatory one, except that no one is regulating ...

Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...

Cardinal Health's pharmaceutical and specialty solutions segment profit increased 7% to $531 million in the second quarter.

Valiquette also increased his earnings per share (EPS) estimates for Cardinal Health (NYSE:CAH), raising the fiscal year 2025 forecast from $7.90 to $7.95 and the fiscal year 2026 projection from $8 ...

Citi analyst Daniel Grosslight increased the price target for Cardinal Health (NYSE:CAH) shares to $130 from the previous ...

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...

Dublin City Schools is officially withdrawing from an agreement with Cardinal Health to purchase a vacant office building, Superintendent John Marschhausen told board members at a meeting Monday ...

Cardinal Health gets downgraded to a hold ... in this segment is that of regulatory and legal costs involving medical products and drugs. From its profile, what this firm is known for is a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Headquartered in Dublin, OH, Cardinal Health Inc. is a nation-wide drug ... Pharmaceutical and Specialty Solutions, Global Medical Products and Distribution and Others. CAH sits at a Zacks Rank ...